A detailed history of New York State Common Retirement Fund transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 137,386 shares of REGN stock, worth $92.8 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
137,386
Previous 146,955 6.51%
Holding current value
$92.8 Million
Previous $154 Million 6.49%
% of portfolio
0.2%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$1024.09 - $1201.76 $9.8 Million - $11.5 Million
-9,569 Reduced 6.51%
137,386 $144 Million
Q2 2024

Jul 31, 2024

BUY
$883.2 - $1071.19 $918,528 - $1.11 Million
1,040 Added 0.71%
146,955 $154 Million
Q1 2024

May 07, 2024

SELL
$902.69 - $993.35 $3.87 Million - $4.25 Million
-4,283 Reduced 2.85%
145,915 $140 Million
Q4 2023

Feb 01, 2024

SELL
$775.18 - $881.7 $9.41 Million - $10.7 Million
-12,140 Reduced 7.48%
150,198 $132 Million
Q3 2023

Nov 07, 2023

SELL
$692.45 - $844.37 $5.43 Million - $6.62 Million
-7,839 Reduced 4.61%
162,338 $134 Million
Q2 2023

Aug 07, 2023

SELL
$700.03 - $830.35 $4.48 Million - $5.31 Million
-6,396 Reduced 3.62%
170,177 $122 Million
Q1 2023

May 02, 2023

SELL
$680.49 - $826.97 $6.05 Million - $7.36 Million
-8,897 Reduced 4.8%
176,573 $145 Million
Q4 2022

Jan 30, 2023

BUY
$705.89 - $766.39 $32,470 - $35,253
46 Added 0.02%
185,470 $134 Million
Q3 2022

Nov 08, 2022

SELL
$573.97 - $724.32 $5.11 Million - $6.44 Million
-8,896 Reduced 4.58%
185,424 $128 Million
Q2 2022

Aug 04, 2022

SELL
$548.35 - $738.84 $3.32 Million - $4.47 Million
-6,046 Reduced 3.02%
194,320 $115 Million
Q1 2022

May 05, 2022

BUY
$595.12 - $698.43 $2.45 Million - $2.87 Million
4,110 Added 2.09%
200,366 $140 Million
Q4 2021

Feb 02, 2022

SELL
$543.48 - $670.97 $1.01 Million - $1.24 Million
-1,852 Reduced 0.93%
196,256 $124 Million
Q3 2021

Nov 02, 2021

SELL
$574.03 - $680.96 $1.93 Million - $2.29 Million
-3,370 Reduced 1.67%
198,108 $120 Million
Q2 2021

Aug 02, 2021

BUY
$472.8 - $558.54 $4.75 Million - $5.61 Million
10,042 Added 5.25%
201,478 $113 Million
Q1 2021

May 11, 2021

SELL
$446.73 - $548.2 $844,319 - $1.04 Million
-1,890 Reduced 0.98%
191,436 $90.6 Million
Q4 2020

Feb 08, 2021

SELL
$478.3 - $607.98 $4.64 Million - $5.9 Million
-9,700 Reduced 4.78%
193,326 $93.4 Million
Q3 2020

Nov 05, 2020

SELL
$544.75 - $658.21 $5.11 Million - $6.17 Million
-9,381 Reduced 4.42%
203,026 $114 Million
Q2 2020

Aug 07, 2020

BUY
$493.32 - $643.92 $10.9 Million - $14.2 Million
22,070 Added 11.6%
212,407 $132 Million
Q1 2020

May 06, 2020

SELL
$336.18 - $494.43 $549,318 - $807,898
-1,634 Reduced 0.85%
190,337 $92.9 Million
Q4 2019

Feb 05, 2020

SELL
$274.13 - $376.51 $7.07 Million - $9.71 Million
-25,783 Reduced 11.84%
191,971 $72.1 Million
Q3 2019

Nov 07, 2019

BUY
$273.46 - $318.39 $1.99 Million - $2.32 Million
7,275 Added 3.46%
217,754 $60.4 Million
Q2 2019

Aug 09, 2019

BUY
$299.6 - $414.82 $5.02 Million - $6.94 Million
16,740 Added 8.64%
210,479 $65.9 Million
Q1 2019

May 08, 2019

BUY
$372.08 - $439.57 $2 Million - $2.36 Million
5,364 Added 2.85%
193,739 $79.6 Million
Q4 2018

Feb 08, 2019

SELL
$335.82 - $403.04 $4.73 Million - $5.67 Million
-14,074 Reduced 6.95%
188,375 $70.4 Million
Q3 2018

Nov 07, 2018

SELL
$351.14 - $408.51 $1.05 Million - $1.23 Million
-3,000 Reduced 1.46%
202,449 $81.8 Million
Q2 2018

Aug 10, 2018

SELL
$284.6 - $344.99 $1.51 Million - $1.83 Million
-5,300 Reduced 2.51%
205,449 $70.9 Million
Q1 2018

May 10, 2018

SELL
$315.82 - $393.78 $5.1 Million - $6.36 Million
-16,160 Reduced 7.12%
210,749 $72.6 Million
Q3 2017

Nov 06, 2017

SELL
$431.38 - $504.0 $1.32 Million - $1.54 Million
-3,063 Reduced 1.33%
226,909 $101 Million
Q2 2017

Aug 11, 2017

BUY
N/A
229,972
229,972 $113 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.